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Endoftalmitis infecciosa tras cirugía de 
cataratas realizada durante 7 años. El papel de 
azitromicina versus ciprofloxacino tópico
Introducción. Aunque la aplicación de antibióticos tópi-
cos se ha utilizado como profilaxis antibiótica tras cirugía 
ocular, estudios recientes han determinado que el uso de ce-
furoxima intracameral como profilaxis tras cirugía ocular ha 
reducido de forma significativa la aparición de infecciones y 
sugiere que el uso de antibióticos tópicos como profilaxis de 
endoftalmitis infecciosa post-operatoria (IPOE) es controver-
tido. Además, no existe evidencia que confirme la eficacia de 
ciprofloxacino tópico, considerado como la terapia estándar, o 
azitromicina tópica en la prevención de IPOE.
Pacientes y métodos. La profilaxis tópica para prevenir la 
IPOE, se realizó siguiendo dos estrategias: azitromicina tópica 
en el periodo entre 1 enero de 2010 al 31 de diciembre de 2014 
(Grupo I) y ciprofloxacino en el periodo entre 1 de enero de 
2015 al 31 de diciembre de 2017 (Grupo II). Se recogieron las 
características de los pacientes y los signos y síntomas clínicos 
de IPOE de las cirugías realizadas durante los 7 años. 
Resultados. Se realizaron un total de 15.146 cataratas: 
10.756 en el Grupo I y 4.390 en el Grupo II. Se diagnostica-
ron dos casos de IPOE en cada grupo, presentando una tasa 
de 0,019% y 0,046% respectivamente, sin diferencias estadísti-
camente significativas. Los casos de IPOE se relacionaron con 
edad avanzada, comorbilidades sistémicas u oculares o con 
cirugías complicadas. 
Conclusiones. El beneficio de la aplicación de antibiótico 
tópico después de cirugía de cataratas es cuestionable siem-
pre que se realice profilaxis con cefuroxima intracameral y no 
se encontró una mayor protección con ciprofloxacino o con 
azitromicina
Palabras clave: cirugía de cataratas, endoftalmitis infecciosa post-operato-
ria, antibióticos tópicos
ABSTRACT
Introduction. Although topical antibiotics have been used 
as antimicrobial prophylaxis after ocular surgery, recent studies 
have determined that intracameral cefuroxime at the end of 
surgery significantly reduce the risk to suffer an infection and 
suggest that the use of topical antibiotics in the prophylaxis of 
infectious postoperative endophthalmitis (IPOE) is controversial. 
Moreover, there is no evidence to confirm the higher effective-
ness of topical ciprofloxacin, considered the standard of care, or 
topical azithromycin in preventing IPOE of cataract surgeries. 
Patients and methods. IPOE topical prophylaxis was per-
formed with two different strategies: with azithromycin from 
January 1st, 2010 to December 31st, 2014 (group I) and with 
ciprofloxacin from January 1st, 2015 to January 31st, 2017 
(group II). Patient characteristics and clinical signs and symp-
toms of IPOE from all consecutive cataract surgeries performed 
over a 7-year period were collected. 
Results. A total of 15,146 cataract surgeries were con-
ducted; 10,756 in group I and 4,390 in group II. Two cases of 
IPOE in each group were diagnosed, showing a 0.019% and 
0.046% rate respectively, with no statistically significance. IP-
OE cases were related with aging, systemic and ocular comor-
bidities or with a complicated cataract surgery. 
Conclusions. The benefit of the application of topical an-
tibiotics after cataract surgery is questionable when intracam-
eral cefuroxime prophylaxis is performed and no better effec-
tiveness with ciprofloxacin or azithromycin was observed.
Key words: cataract surgery, infectious postoperative endophtalmitis, 
topical antibiotics
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been questioned, some developed countries still maintain this 
practice. The main purpose of this retrospective study was to 
assess the role of topical azithromycin or topical ciprofloxa-
cin in addition to what is considered the standard of care in 
preventing IPOE, intracameral cefuroxime or vancomycin, in a 
long series of cataract surgeries.
PATIENTS AND METHODS
All surgeries were performed at the Hospital de la Esper-
anza (Barcelona, Catalonia, Spain). This institution belongs to 
the group Parc de Salut Mar, which is a 3rd level center and 
serves a population of approximately 330,000 inhabitants. This 
population has a mean age of 43 years and a life expectancy of 
80 years for males and 85 for females. 
All consecutive cataract surgeries performed between 
January 1, 2010 and January 31, 2017 were included. Topical 
antibiotic for IPOE prophylaxis was Azydrop (azithromycin de-
hydrate 15 mg/g. Thea lab. Clermont-Ferrand, France) in cases 
operated between January 1, 2010 and December 31, 2014 
(group I). From January 1, 2015 to January 31, 2017 cataract 
surgeries were performed with Cetraflux eye drops (ciproflox-
acin hydrochloride 3 mg/ml, Salvat Lab., Barcelona, Spain) as 
topical antibiotic IPOE prophylaxis (group II).
Institutional review board approval was obtained and the 
study adhered to the Declaration of Helsinki, and has followed 
the rules on confidentiality of data (Organic Law 15/1999 of 
13 Of December of protection of data of personal character 
(LOPD)).
A database collection system for intravitreal antibiotic 
prepared in our hospital pharmacy was consulted. Database 
contains patient medical record number and date of IVI of 
antibiotic. Case-specific information was collected using the 
hospital electronic program for patient’s medical records. En-
dophthalmitis was diagnosed by the physician of record. Vit-
reous biopsy was performed immediately after diagnosis, and 
cultures were sent to the microbiology laboratory.
During the study period all surgeons performed 
phacoemulsification using 2.75mm or 2.2 mm clear corneal 
approach and IOL implantation. From all cases, 88% were done 
under topical anesthesia and 12% with retrobulbar injection. 
Povidone–iodine solution 5% was started outside the operat-
ing theater and timed to be applied as 1 drop into the con-
junctival sac and onto the cornea for a minimum of 3 minutes 
before surgery. Povidone-iodine 10% was used for surgical skin 
field antiseptic preparation. In patients with history of aller-
gy to topical iodine the prophylactic antisepsis was done with 
chlorhexidine 0.05%. Eyelids and lashes were draped away 
from surgery field. Intracameral cefuroxime (1 mg/0.1 ml) or 
vancomycin (1 mg/0.1 ml) in case of β-lactam allergy were 
used in all procedures. Intracameral antibiotic solutions were 
compounded in our hospital pharmacy. Topical antibiotic eye 
drops were also prescribed, group one received azithromycin 
eye drops twice daily for three days, starting the day before 
surgery. Patients in group two received topical ciprofloxa-
INTRODUCTION
Cataract extraction with intraocular lens (IOL) implanta-
tion is the most commonly performed surgical procedure in 
the elderly population over the world, with 22 million of cat-
aract surgeries per year [1]. Infectious postoperative endoph-
thalmitis (IPOE) is the most dreaded complication of cataract 
surgery. It is also responsible for permanent and significant 
loss of vision, so huge efforts have to be done to avoid IPOE. 
Endophthalmitis is a serious intraocular inflammatory disorder 
resulting from infection of the vitreous cavity. Progressive vit-
ritis is the hallmark of any form of endophthalmitis. Most pres-
ent within 1-2 weeks, usually 3-5 days after the surgery. Ini-
tial symptoms are rapidly progressive, including pain, red eye, 
ocular discharge, and blurring. Most common signs include 
decreased visual acuity, lid swelling, conjunctival and corneal 
edema, anterior chamber cells + fibrin, hypopyon, vitreous in-
flammation, retinitis, and blunting of red reflex.
Povidone-iodine application of a 5% solution on the con-
junctiva prior to surgery was found to reduce the rate of en-
dophthalmitis by four fold [2].
The prospective randomized endophthalmitis prophylaxis 
trial of the European Society of Cataract and Refractive Sur-
geons (ESCRS) had reported a 5-fold reduction in endophthal-
mitis rates with direct intracameral injection of cefuroxime at 
the conclusion of cataract surgery (0.07% versus 0.34% with-
out intracameral cefuroxime) [3,4]. Other studies in Europe 
have confirmed this reduction in the postoperative endoph-
thalmitis rates with the systematic use of intracameral cefuro-
xime [5-7].
Topical antibiotics role in the prophylaxis of IPOE is con-
troversial. Recent evidence suggests that topical antibiotics 
after intravitreal injection (IVI) may even be harmful by in-
creasing antibiotic-resistant bacterial strains [8-12]. However, 
topical antibiotic long has been the standard of care after ocu-
lar surgery, and this practice is carried over to ocular injections 
after a preoperative topical instillation of povidone-iodine 
[2,13] and intracameral antibiotic injection at the end of cata-
ract surgery [14,15].
It is not known if the use of different families of antibiot-
ics at the end of cataract surgery could affect the incidence of 
IPOE. The use of ciprofloxacin eye drops as antibiotic prophy-
laxis has been the usual practice to prevent ocular infections. 
Also, it seems that fluoroquinolones like ciprofloxacin have 
good pharmacokinetics properties and its penetration to the 
aqueous humor after topical administration could allow to 
have enough antibiotic concentration to treat infections [16, 
17]. Azithromycin is a broad spectrum antibiotic that covers 
most commonly found bacteria in the environment, and also 
could not increase antimicrobial resistance in conjunctive flo-
ra as much as ciprofloxacin. On the other hand, information 
about its penetration to the aqueous humor is lacking, but 
some studies suggest that macrolides like clarithromycin could 
achieve therapeutic levels after topical administration [18].
Even though the topical administration of antibiotics has 
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and more than 1000 cataract surgeries performed. If not, was 
considered a “novel” surgeon.
“Quantitative variables were described as median. Cat-
egorical variables were described as frequency (percentage). 
Possible associated factors to suffer IPOE were evaluated by 
the chi-squared test for categorical variables and Fisher’s ex-
act test for continuous variables. Associations with a p-value 
<0.05 were considered statistically significant. Statistical anal-
ysis were done with the STATA 15.0 software (Stata Corp.; Col-
lege Station, Texas, USA).”
RESULTS
Fifteen thousand one hundred and forty-six consecutive 
cataract surgeries were performed between January 1, 2010 
and January 31, 2017. From January 1, 2010 to December 31, 
2014, 10,756 cataract surgeries were performed with azith-
romycin eye drops for IPOE prophylaxis (group I). During this 
period, two cases of IPOE were diagnosed, what means a rate 
of 0.019%. One patient’s vitreous culture showed no growth 
but clinical presentation, patient signs and symptoms and loss 
of visual acuity (VA) were consistent for IPOE. Between January 
1, 2015 and January 31, 2017, 4,390 cataract surgeries were 
performed with ciprofloxacin eye drops as topical antibiotic 
treatment for IPOE prophylaxis (group II). Two IPOE cases pre-
cin eye drops every 8 hours for one week, starting the same 
day of surgery. Patients received also steroid eye drops: dexa-
methasone 1mg/ml (Dexametasona, Alcon Cusí lab. Barcelona, 
Spain) every 2 h for the first 24h postoperative and then in 
a descending pattern (one drop every 6h first week, every 8h 
second week, every 12h the third and every 24h the fourth).
Postoperative endophthalmitis is an inflammatory condi-
tion of the eye, presumed to be due to an infectious process 
from bacteria, fungi or, on rare occasions, parasites that enter 
the eye during the perioperative period. If a patient presents 
with sudden decrease in visual acuity early after cataract sur-
gery, often with pain and signs of diffuse intraocular inflam-
mation (vitreous infiltration, hypopyon, red eye), infectious 
endophthalmitis should be suspected [19, 19b]
Surgeons did the follow-up of patients for at least 2 
months. Scheduled visits were at first day postop, one week 
and 6-8 weeks.
Only 0.5% of patients were excluded for not attending 
any of the scheduled visits.
From the electronic medical record, data were collected 
regarding the comorbidity of the patient, such as immunode-
ficiency, diabetes or hypertension, the duration of the cataract 
surgery and the experience of the surgeon, since these factors 
could increase the risk of IPOE. Physician was defined as an 
“expert” surgeon when had more than 5 years of experience 
Topical antibiotic Gender Age General background Ophthalmic background Surgery IPOE Vitreous Culture Final VA
Azithromycin Male 85 DMII- OAD
Dyslipidaemia
Pseudoexfoliation
Glaucoma-
prostaglandin treatment
Myosis
Pre-VA RE: 0.5
Expert surgeon
IFIS
23 minutes surgery
8 days’ post-surgery
IV AB + Topical reinforced eye 
drops + posterior vitrectomy
Coagulase 
negative 
Staphylococcus
0.5
Azithromycin Male 71 Alcoholic liver disease, 
smoking, epilepsy, 
barbiturate intake
Mature cataract +++
Pre VA LE: 0.05
Novel surgeon
25 minutes surgery
7 days’ post-surgery
IV AB + Topical reinforced eye 
drops + posterior vitrectomy
Negative 0.6
Ciprofloxacin Female 90 Alzheimer
Depression
Arterial hypertension
Obesity
Pseudoexfoliation
Phacodonesis
Pre VA LE: CF
Expert surgeon
Stretching
28 minutes surgery
14 days’ post-surgery
IV AB + Topical reinforced eye 
drops + posterior vitrectomy
Negative HM
Ciprofloxacin Male 73 Glaucoma
Myopia
Pre VA RE: 0.4
Novel surgeon
Zonular dialysis
Phenylephrine
Iris hooks
Anterior vitrectomy
31 minutes surgery
2 days’ post-surgery
IV AB + Topical reinforced eye 
drops + posterior vitrectomy
Negative 0.8
Table 1 IPOE cases demographic and clinical data
IPOE: infectious postoperative endophthalmitis, DMII: Mellitus Diabetes type II, OAD: oral antidiabetics, Pre VA: previous Visual Acuity, RE: Right Eye, LE: Left Eye, 
IV AB: Intravitreal Antibiotics.
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In the azithromycin group 95% of patients received intra-
cameral cefuroxime versus 96% in the ciprofloxacin group (no 
statistical differences). The rest of the patients in each group 
were treated with intracameral vancomycin. 
DISCUSSION
The present study carried out on approximately 15,000 
cataract procedures in two groups of antibiotics, azithromycin 
versus ciprofloxacin, were compared, did not show statistically 
significant differences in the appearance of IPOE.
The role of antibiotic prophylaxis of IPOE using different 
routes of administration is controversial. With the increasing 
adoption of topical anesthesia for cataract surgery, the use of 
sub-conjunctival antibiotic is bound to wane. Eight percent of 
surgeons in the 2014 ASCRS survey [19] reported use of irriga-
tive antibiotic during cataract surgery although high-quality ev-
idence either supporting or refuting this practice is lacking [14].
sented, that is a 0.046% rate. The differences in incidence of 
endophthalmitis were not statistically significant.
Overall, four IPOE cases were detected, what means an 
overall rate of 0.026%.
Three of our four IPOE cases were related with aging and 
systemic and ocular co-morbidities and were operated on, two 
by an expert cataract surgeon and the other one by a novel 
ophthalmologist. The fourth case did not have important co-
morbidities, but was a complicated cataract surgery done by a 
novel surgeon (table 1).
The clinical and demographic data of the patients are 
summarized in table 2. There were no differences between the 
groups in terms of age, laterality or incidence of arterial hyper-
tension. There were a higher percentage of diabetics in group 
I (p <0.013). Perioperative complications and surgical time 
were also different, with a higher incidence of complications (p 
<0.001) and longer surgical time (p <0.0001) in group II (cipro-
floxacin) (figure 1 and table 2).
Group
Number Age
(years)
Female 
Gender
RE Diabetes
Arterial  
hypertension
Surgical complications Surgical time
(minutes)Eyes Patients PC rupture Zonulolysis Vitreous loss Total
Total 15,146 12,847 74.9 59.2% 49.85% 25.96% 61.4% 0.37% 0.18% 0.48% 1.03% 18.36
Azithromycin 10,756 9,202 74.87 59.0% 49.72% 26.53% 61.4% 0.34% 0.03% 0.39% 0.76% 17.6
Ciprofloxacin 4,390 3,645 74.98 59.4% 50.17% 24.61% 61.5% 0.42% 0.53% 0.68% 1.63% 20.6
P-value* 0.5 0.6 0.013 0.9 0.001 0.001 0.001 0.001 0.0001
Table 2  Demographic and clinical data
*P-values refers to azithromycin versus ciprofloxacin comparison. RE: Right eye. PC rupture: Posterior capsule rupture.
PC rupture: Posterior capsule rupture.
Figure 1 Surgical complications
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and we thought fluoroquinolones must be reserved for ocular 
infections, in order to avoid increase antimicrobial resistance 
among conjunctival flora. Commercially available ophthalmic 
azithromycin is a preservative free formulation that allows for 
a short period treatment (twice daily only for 3 days). Resid-
ual azithromycin levels observed 7 days after the last topical 
administration were above the minimum inhibitory concentra-
tion of 0.5 µg/g in the conjunctiva and cornea. This permits 
topical administration twice daily for three days resulting in 
significant concentrations in the conjunctiva and cornea for at 
least 7 days after final administration [26]. These characteris-
tics make azithromycin an AB with a very comfortable dosage 
for patients and no risk for allergies due to the preservatives. 
Due to regulations of the competent health authorities in our 
country, we had to replace azithromycin with ciprofloxacin in 
the prophylaxis of IPOE. Our results are according with oth-
er series using intracameral cefuroxime as unique antibiotic 
prophylaxis in cataract surgery [3-7, 27, 28]. To our knowledge, 
this is the first series using topical azithromycin plus intracam-
eral cefuroxime for IPOE prophylaxis in cataract surgery. 
Though this is a retrospective study, azithromycin did not 
cause any increase in IPOE cases, quite the opposite. Moreo-
ver, our hospital is a public educational institution and there 
are residents performing cataract surgery. The population we 
attend belongs to the most depressed area of the city, so that 
our patients have lower hygienic health level. And our IPOE 
rates are low indeed, so that is why we feel prophylaxis with 
azithromycin is equal in terms of preventing IPOE than that 
with ciprofloxacin.
As observed in our study, other studies have shown that 
experienced surgeons are more likely to be associated with IP-
OE cases because they use to be involved in more complicated 
cases [4]. Other authors found the more experienced surgeons 
associate a 5-fold difference in reducing the risk for IPOE [29]. 
The differences between both groups regarding perioperative 
complications and surgical time are related to the volume of 
surgeries performed by novel surgeons, which represents 15% 
in group I and near 40% in group II. Surgical time was some-
what longer in the ciprofloxacin group, but the difference (3 
minutes), although statistically significant, would not be clin-
ically relevant. In fact, although both intraoperative compli-
cations and surgical time are different in the two groups, the 
IPOE case was negligible, so we did not consider performing a 
statistical analysis more adjusted to the infection rate. 
Fluoroquinolone-associated collagen toxicity has been de-
scribed in previous studies with a long duration antimicrobial 
treatment (over 7 days) after oral or endovenous administra-
tion. [30, 31]. Nevertheless, since in our study ciprofloxacin ap-
plication was topical this kind of toxicity could be discarded. 
The role of topical antibiotic in the prophylaxis of IPOE is 
controversial. Herrinton [32] showed that risk for IPOE is dou-
ble for patients that had no evidence of antibiotic prophylaxis, 
42% reduction in risk associated with intracameral antibiotic 
administration and no differences in risk between intracameral 
agent alone and intracameral plus topical agent. 
The efficacy of prophylactic intracameral cefuroxime in 
preventing endophthalmitis after cataract surgery was sug-
gested by retrospective data from Sweden [20] and later by 
other studies carried out in Europe and the USA [15,20]. This 
finding was further substantiated by the ESCRS multicenter 
study of postoperative endophthalmitis that remains, to date, 
the only prospective, randomized, placebo-control trial of 
prophylactic antibiotic use in cataract surgery [3, 4]. Results 
showed that the use of intracameral cefuroxime reduces the 
risk of IPOE to approximately one-fifth the value observed 
without this prophylaxis [3, 4]. These results would reinforce 
the role of the intracameral administration of cefuroxime or 
vancomycin in cataract surgery and question the potential 
benefit of the subsequent instillation of eye drops with antibi-
otics. However, according to the 2014 ASCRS survey [19], pe-
rioperative topical antibiotic prophylaxis continues to be used 
by the overwhelming majority of surgeons in the USA. Actually, 
97% of the surgeons uses a postoperative topical antibiotic and 
fourth generation quinolones (moxifloxacin and gatifloxacin) 
are the antibiotic most prescribed.
The most common strains from conjunctival isolates 
are found to be coagulase-negative Staphylococcus (CNS), 
Staphylococcus epidermidis and Staphylococcus aureus [12]. 
The Endophthalmitis Vitrectomy Study Group [18] revealed 
that 70% of infections were caused by CNS followed by 9.9% 
S. aureus. So organisms typically associated with conjunctival 
flora are those seen in IPOE after cataract surgery [21]. 
Moreover, some risk factors for endophthalmitis have been 
associated with more pathogenic conjunctival bacteria [22]. 
Age was associated with increased bacteria in general, S. 
aureus was associated with diabetes, lung disease, and renal 
and heart insufficiency, and Gram-negative rods with smoking 
habit [22]. In all cases, comorbidities considered as a risk factor 
to develop IPOE were observed.
Several studies have demonstrated that a large propor-
tion of conjunctival bacteria, specifically pathogenic ones 
(CNS and S. aureus) are resistant to β-lactams, azithromycin 
or fluoroquinolones [7,23]. Moreover, there is evidence that 
the percentage of S. epidermidis isolated from the conjunc-
tival surface significantly increases after repeated exposure to 
azithromycin or fluoroquinolones [9-11]. Furthermore, Miller et 
al [24] reported higher rates of fluoroquinolone resistance in 
CNS recovered from patients with endophthalmitis than would 
have been predicted based on surveillance studies. 
Regional differences in conjunctival bacterial flora can 
not only determine different risk of incidence of endophthal-
mitis but worse outcome with poor final VA as suggested by 
Mesnard [25] that reports 8.5-fold reduction in postoperative 
endophthalmitis after introduce Aprokam for intracameral use, 
but finds more IPOE associated with Streptococcus sp. and 
gram-negative microorganisms which were found in series 
from USA or Europe.
We selected azithromycin as topical antibiotic prophylaxis 
in our patients because it is a broad spectrum antibiotic that 
covers most commonly found bacteria in the environment, 
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We found that the risk for IPOE was the same with peri-
operative topical ciprofloxacin than with topical azithromycin. 
Although conjunctival and lid margin isolates are not too sen-
sitive to azithromycin [33], topical antibiotic are able to eradi-
cate in vitro resistant strains in patients and provide the same 
cure rate for both susceptible and resistant strains [33] because 
of the high local concentrations that are reached and the local 
physicochemical conditions that may influence the overall ac-
tivity of the agent at the site of application. 
It has been proved for IVI that topical antibiotics drops 
not only do not reduce the risk for post injection endophthal-
mitis but it is increased [34,35]. It is remarkable that periop-
erative topical antibiotic prophylaxis continues to be used by 
the overwhelming majority of surgeons (97%) in the USA [21] 
and only 30% of US surgeons in the 2014 ASCRS survey were 
injecting intracameral antibiotic at the conclusion of surgery 
[36]. We suspect that cefuroxime labeled for intracameral use 
(Aprokam, Thea lab) approval will change this reality, because 
the published evidence for antibiotic prophylaxis is strongest 
for direct intracameral injection.
The main limitation of our study is its retrospective design 
and, despite being a one site large sample, the low incidence 
of IPOE makes it difficult to obtain definitive conclusions, but 
it seems that topical antibiotic prophylaxis with azithromycin 
is not better than the one with ciprofloxacin when associated 
with intracameral cefuroxime. Moreover, topical antibiotic ad-
ministration is questionable and the low percentage of IPOE 
is probably attributable to the intracameral administration of 
cefuroxime or vancomycin.
In conclusion, as topical antibiotic administration is ques-
tionable for IPOE prophylaxis when intracameral administra-
tion of cefuroxime or vancomycin is performed, and azithro-
mycin showed no benefit front ciprofloxacin, which has been 
the usual practice to prevent ocular infections, the application 
of topical antibiotic in addition to the intracameral antibiotic 
administration is a practice that should be avoided, since there 
is no benefit observed and could increase antibiotic-resistant 
bacterial strains.
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